CA
Clearstead Advisors Portfolio holdings
AUM
$7.09B
This Quarter Return
-0.19%
1 Year Return
+14.95%
3 Year Return
+61.54%
5 Year Return
+112.35%
10 Year Return
–
AUM
$1.34B
AUM Growth
+$1.34B
(+2.8%)
Cap. Flow
+$38.8M
Cap. Flow
% of AUM
2.9%
Top 10 Holdings %
Top 10 Hldgs %
37.99%
Holding
1,445
New
175
Increased
394
Reduced
252
Closed
134
Top Buys
| 1 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
$6.88M |
| 2 |
Ares Capital
ARCC
|
$4.88M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
$3.2M |
| 4 |
ProShares Ultra QQQ
QLD
|
$2.09M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
$1.87M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.34M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
$1.45M |
| 3 |
Wells Fargo
WFC
|
$1.27M |
| 4 |
Apple
AAPL
|
$1.14M |
| 5 |
Steris
STE
|
$999K |
Sector Composition
| 1 | Technology | 12.57% |
| 2 | Financials | 9.9% |
| 3 | Healthcare | 6.51% |
| 4 | Consumer Discretionary | 5.58% |
| 5 | Industrials | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Target
TGT
$42B
| $5.69M | 0.42% |
24,873
-1,227
| -5% | -$281K |
|
52
Nike
NKE
$110B
| $5.65M | 0.42% |
38,895
-1,251
| -3% | -$182K |
|
53
Pfizer
PFE
$141B
| $5.64M | 0.42% |
131,031
-4,796
| -4% | -$206K |
|
54
iShares Russell 2000 ETF
IWM
$66.6B
| $5.61M | 0.42% |
25,627
+1,036
| +4% | +$227K |
|
55
UnitedHealth
UNH
$279B
| $5.32M | 0.4% |
13,624
-611
| -4% | -$239K |
|
56
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $5.12M | 0.38% |
101,322
+35,789
| +55% | +$1.81M |
|
57
Mastercard
MA
$536B
| $5.09M | 0.38% |
14,629
-104
| -0.7% | -$36.2K |
|
58
3M
MMM
$81B
| $4.92M | 0.37% |
28,056
+582
| +2% | +$102K |
|
59
Coca-Cola
KO
$297B
| $4.9M | 0.37% |
93,472
-9,048
| -9% | -$475K |
|
60
Bank of America
BAC
$371B
| $4.88M | 0.36% |
114,929
-2,741
| -2% | -$116K |
|
61
Vanguard Dividend Appreciation ETF
VIG
$95.1B
| $4.64M | 0.35% |
30,177
+693
| +2% | +$106K |
|
62
iShares S&P 500 Growth ETF
IVW
$63.2B
| $4.58M | 0.34% |
62,018
+1,652
| +3% | +$122K |
|
|
63
Steris
STE
$23.9B
| $4.41M | 0.33% |
21,583
-4,889
| -18% | -$999K |
|
64
Oracle
ORCL
$628B
| $4.39M | 0.33% |
50,391
-2,017
| -4% | -$176K |
|
65
Bristol-Myers Squibb
BMY
$96.7B
| $4.31M | 0.32% |
72,753
+1,403
| +2% | +$83K |
|
66
Eli Lilly
LLY
$661B
| $4.07M | 0.3% |
17,607
+133
| +0.8% | +$30.7K |
|
67
Meta Platforms (Facebook)
META
$1.85T
| $3.97M | 0.3% |
11,697
+444
| +4% | +$151K |
|
68
Brookfield Infrastructure
BIPC
$4.68B
| $3.92M | 0.29% |
65,443
-131
| -0.2% | -$7.83K |
|
69
Danaher
DHR
$143B
| $3.88M | 0.29% |
12,751
-1,049
| -8% | -$319K |
|
70
Schwab US Mid-Cap ETF
SCHM
$12B
| $3.88M | 0.29% |
50,604
+20,397
| +68% | +$1.56M |
|
71
iShares Select Dividend ETF
DVY
$20.6B
| $3.85M | 0.29% |
33,545
-3,344
| -9% | -$384K |
|
72
iShares S&P 500 Value ETF
IVE
$40.9B
| $3.83M | 0.29% |
26,347
-210
| -0.8% | -$30.5K |
|
73
Vanguard FTSE All-World ex-US ETF
VEU
$48.3B
| $3.62M | 0.27% |
59,309
-2,904
| -5% | -$177K |
|
74
Chevron
CVX
$318B
| $3.6M | 0.27% |
35,443
-735
| -2% | -$74.6K |
|
75
SPDR Gold Trust
GLD
$111B
| $3.59M | 0.27% |
21,849
-547
| -2% | -$89.8K |
|